đź“‹ FDA Reference

Philips Multidiagnost 4

Philips Medical Systems

Compare similar devices

Summary: The Philips Multidiagnost 4 is a medical imaging device used primarily for diagnostic and interventional procedures. It is utilized by radiologists and interventional specialists to visualize and treat various conditions.

FDA Clearance Information

Pathway ? 510(k)
Number ? K961374 ↗
Decision Date ? August 19, 1996
Product Code ? OWB
Device Class ? Class 2
Evidence ? 419 studies

The Philips Multidiagnost 4 was cleared by the FDA through the 510k pathway on August 19, 1996. It is manufactured by Philips Medical Systems and classified as a Class 2 device under product code OWB.

What It Is

The Philips Multidiagnost 4 is a versatile fluoroscopy system designed for both diagnostic imaging and interventional procedures. It provides real-time X-ray imaging, allowing clinicians to visualize internal structures and guide interventions. The system is equipped with advanced imaging capabilities to enhance visualization during complex procedures.

FDA-Cleared Indications

  • Use for diagnostic and interventional procedures requiring real-time fluoroscopic X-ray imaging.
  • Use with liquid embolization agents when fluoroscopic imaging is needed to guide delivery and assess treatment.
  • Use for imaging of internal anatomy during procedures performed with compatible catheters and other interventional devices.

Clinical Applications

  • Fluoroscopic guidance during catheter-based diagnostic examinations.
  • Image guidance for delivery of liquid embolization agents.
  • Real-time visualization of vascular anatomy during interventional procedures.
  • Monitoring device position and treatment effect during image-guided procedures.

Reported off-label uses

  • Fluoroscopic guidance for gastrointestinal and genitourinary procedures when clinically appropriate.
  • Fluoroscopic guidance for orthopedic or pain-management injections.
  • General radiographic or fluoroscopic guidance for procedures outside the specific FDA-cleared labeling, based on institutional practice and clinician judgment.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The system uses ionizing radiation; dose optimization, shielding, collimation and fluoroscopy-time monitoring are important.
  • Confirm compatibility between the imaging system, procedure table, catheters, guidewires, contrast agents and liquid embolization materials used in the procedure.
  • This is an X-ray fluoroscopy system, not an MRI scanner. Patients with implanted devices should be evaluated according to the implant manufacturer's MRI conditions if MRI is being considered separately.
  • Use requires trained personnel familiar with fluoroscopic imaging, radiation safety, sterile technique and management of contrast-related complications.
  • The system's age, maintenance status, software, image quality and availability of replacement parts should be verified before clinical use.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is Philips Multidiagnost 4 used for?

It is used for diagnostic imaging and interventional procedures, including angiography and embolization.

What specialties typically use this device?

Interventional radiology and cardiology specialists commonly use this device.

What are the FDA-cleared indications?

It is indicated for use in procedures involving liquid embolization agents, such as treating vascular malformations or tumors.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you